Preprocedure COVID-19 Testing in Early Phase of Pandemic.

Autor:	Jain R; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health., Kruger B; Advocate Aurora Health, Milwaukee, WI., Citronberg R; Infectious Disease, Advocate Aurora Health, Downers Grove, IL., Kroboth S; Advocate Aurora Research Institute, Milwaukee, WI., Perez Moreno AC; Advocate Aurora Research Institute, Milwaukee, WI., Khandheria BK; Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health.
Jazyk:	angličtina
Zdroj:	Journal of patient-centered research and reviews [J Patient Cent Res Rev] 2021 Apr 19; Vol. 8 (2), pp. 151-153. Date of Electronic Publication: 2021 Apr 19 (Print Publication: 2021).
DOI:	10.17294/2330-0698.1841
Abstrakt:	The COVID-19 pandemic led to a nationwide shutdown of elective medical procedures. Upon resumption of services, preprocedure nasopharyngeal swab testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was introduced for all patients requiring surgical or other aerosol-generating procedures. We investigated preprocedure COVID-19 testing in one of the largest U.S. health systems. Patients included in this retrospective, observational study were asymptomatic and scheduled for a procedure or surgery. All patients underwent a nasopharyngeal swab test for SARS-CoV-2 performed 24-72 hours prior to a planned procedure. Clinical demographics, type of procedure, test results, and subsequent procedure status were evaluated. Of 38,608 total patients, there were 277 COVID-19-positive patients (positivity rate: 0.72%). Of those 277, 244 (88%) had procedural delays or cancellations. Of the COVID-19-negative patients, 50 (0.13%) required later hospitalization for COVID-19. Median time from preprocedure negative test to admission was 46.3 ± 27.2 days. In the largest series published on preprocedure COVID-19 testing in the early phase of the pandemic, preprocedure COVID-19 positivity was low. Preprocedure COVID-19 testing had a significant impact on clinical management. Rate of COVID-19 cases requiring hospitalization in the months following the procedure was negligible, suggesting health system policies adequately protected patient safety. Competing Interests: Conflicts of Interest None. (© 2021 Aurora Health Care, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu